Trademark: 87375678
Word
MAVYRET
Status
Registered
Status Code
702
Status Date
Tuesday, April 30, 2024
Serial Number
87375678
Registration Number
5361413
Registration Date
Tuesday, December 19, 2017
Mark Type
4
Filing Date
Friday, March 17, 2017
Published for Opposition
Tuesday, July 11, 2017

Trademark Owner History
AbbVie Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Jun 1, 2017
Assigned To Examiner
Mar 21, 2017
New Application Entered
Mar 23, 2017
New Application Office Supplied Data Entered
Jun 2, 2017
Approved For Pub - Principal Register
Jun 21, 2017
Notification Of Notice Of Publication E-Mailed
Jul 11, 2017
Published For Opposition
Jul 11, 2017
Official Gazette Publication Confirmation E-Mailed
Sep 5, 2017
Noa E-Mailed - Sou Required From Applicant
Oct 20, 2017
Teas Statement Of Use Received
Oct 20, 2017
Use Amendment Filed
Nov 6, 2017
Case Assigned To Intent To Use Paralegal
Nov 6, 2017
Statement Of Use Processing Complete
Nov 16, 2017
Allowed Principal Register - Sou Accepted
Nov 17, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 19, 2017
Registered-Principal Register
Dec 19, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 31, 2023
Teas Section 8 & 15 Received
Apr 30, 2024
Case Assigned To Post Registration Paralegal
Apr 30, 2024
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Apr 30, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24